|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Duma NR, Santana-Davila and Molina JR:
Non-small cell lung cancer: Epidemiology, screening, diagnosis, and
treatment. Mayo Clin Proc. 94:1623–1640. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ettinger DS, Wood DE, Akerley W, Bazhenova
LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA,
Demmy TL, et al: Non-small cell lung cancer, version 1.2015. J Natl
Compr Canc Netw. 12:1738–1761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gompelmann D, Eberhardt R and Herth FJ:
Advanced malignant lung disease: What the specialist can offer.
Respiration. 82:111–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goldstraw P, Chansky K, Crowley J, Porta
RR, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A,
Bolejack V, et al: The IASLC lung cancer staging project: Proposals
for revision of the tnm stage groupings in the forthcoming (Eighth)
edition of the TNM classification for lung cancer. J Thorac Oncol.
11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi WI, Lee DY, Choi HG and Lee CW: Lung
cancer development and mortality in interstitial lung disease with
and without connective tissue diseases: A five-year nationwide
population-based study. Respir Res. 20:1172019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sève P, Reiman T and Dumontet C: The role
of betaIII tubulin in predicting chemoresistance in non-small cell
lung cancer. Lung Cancer. 67:136–143. 2010. View Article : Google Scholar
|
|
8
|
Wei S, Zheng Y, Jiang Y, Li X, Geng J,
Shen Y, Li Q, Wang X, Zhao C, Chen Y, et al: The circRNA circPTPRA
suppresses epithelial-mesenchymal transitioning and metastasis of
NSCLC cells by sponging miR-96-5p. EBioMedicine. 44:182–193. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Raoof S, Mulford IJ, Cabanos HF, Nangia V,
Timonina D, Labrot E, Hafeez N, Bilton SJ, Drier Y, Ji D, et al:
Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant
non-small cell lung cancer. Oncogene. 38:6399–6413. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang F, Yan Y, Yang Y, Hong X, Wang M,
Yang Z, Liu B and Ye L: MiR-210 in exosomes derived from CAFs
promotes non-small cell lung cancer migration and invasion through
PTEN/PI3K/AKT pathway. Cell Signal. 73:109675Sep;2020.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Del Vescovo V, Grasso M, Barbareschi M and
Denti MA: MicroRNAs as lung cancer biomarkers. World J Clin Oncol.
5:604–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng S, Calin GA, Croce CM, Coukos G and
Zhang L: Mechanisms of microRNA deregulation in human cancer. Cell
Cycle. 7:2643–2646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tüfekci KU, Meuwissen RL and Genç S: The
role of microRNAs in biological processes. Methods Mol Biol.
1107:15–31. 2014. View Article : Google Scholar
|
|
14
|
Qian B, Nag SA, Su Y, Voruganti S, Qin JJ,
Zhang R and Cho WC: miRNAs in cancer prevention and treatment and
as molecular targets for natural product anticancer agents. Curr
Cancer Drug Targets. 13:519–541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang C, Chen YX, Wu NY, Yin JY, Li XP,
Huang HS, Zhang W, Zhou HH and Liu ZQ: MiR-488 inhibits
proliferation and cisplatin sensibility in non-small-cell lung
cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling
pathway. Sci Rep. 7:403842017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li T, Ding ZL, Zheng YL and Wang W:
MiR-484 promotes non-small-cell lung cancer (NSCLC) progression
through inhibiting Apaf-1 associated with the suppression of
apoptosis. Biomed Pharmacother. 96:153–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fortunato O, Borzi C, Milione M, Centonze
G, Conte D, Boeri M, Verri C, Moro M, Facchinetti F, Andriani F, et
al: Circulating mir-320a promotes immunosuppressive macrophages M2
phenotype associated with lung cancer risk. Int J Cancer.
144:2746–2761. 2019. View Article : Google Scholar :
|
|
18
|
Ni K, Wang D, Xu H, Mei F, Wu C, Liu Z and
Zhou B: miR-21 promotes non-small cell lung cancer cells growth by
regulating fatty acid metabolism. Cancer Cell Int. 19:2192019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Martello G, Rosato A, Ferrari F, Manfrin
A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T,
et al: A MicroRNA targeting dicer for metastasis control. Cell.
141:1195–1207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cai X, Liu Q, Zhang X, Ren Y, Lei X, Li S,
Chen Q, Deng K, Wang P, Zhang H and Shi D: Identification and
analysis of the expression of microRNA from lactating and
nonlactating mammary glands of the Chinese swamp buffalo. J Dairy
Sci. 100:1971–1986. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng J, Liu Y, Qiao Y, Zhang L and Lu S:
miR-103 promotes proliferation and metastasis by targeting KLF4 in
gastric cancer. Int J Mol Sci. 18:9102017. View Article : Google Scholar :
|
|
22
|
Chen HY, Lin YM, Chung HC, Lang YD, Lin
CJ, Huang J, Wang WC, Lin FM, Chen Z, Huang HD, et al: miR-103/107
promote metastasis of colorectal cancer by targeting the metastasis
suppressors DAPK and KLF4. Cancer Res. 72:3631–3641. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xue D, Zhou C, Lu H, Xu R, Xu X and He X:
LncRNA GAS5 inhibits proliferation and progression of prostate
cancer by targeting miR-103 through AKT/mTOR signaling pathway.
Tumour Biol. 14:10072016.
|
|
24
|
Xia W, Ni J, Zhuang J, Qian L, Wang P and
Wang J: MiR-103 regulates hepatocellular carcinoma growth by
targeting AKAP12. Int J Biochem Cell Biol. 71:1–11. 2016.
View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Poincloux R, Lizárraga F and Chavrier P:
Matrix invasion by tumour cells: A focus on MT1-MMP trafficking to
invadopodia. J Cell Sci. 122:3015–3024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin Q, Fischer L, Noethling C and Schaefer
WR: In vitro- assessment of putative antiprogestin activities of
phytochemicals and synthetic UV absorbers in human endometrial
ishikawa cells. Gynecol Endocrinol. 31:578–581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cortinovis D, Monica V, Pietrantonio F,
Ceresoli GL, Spina CM and Wannesson L: MicroRNAs in non-small cell
lung cancer: Current status and future therapeutic promises. Curr
Pharm Des. 20:3982–3990. 2014. View Article : Google Scholar
|
|
30
|
Boeri M, Pastorino V and Sozzi G: Role of
microRNAs in lung cancer: Microrna signatures in cancer prognosis.
Cancer J. 18:268–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vannini I, Fanini V and Fabbri M:
MicroRNAs as lung cancer biomarkers and key players in lung
carcinogenesis. Clin Biochem. 46:918–925. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsang FH, Au SL, Wei L, Fan DN, Lee JM,
Wong CC, Ng IO and Wong CM: MicroRNA-142-3p and microRNA-142-5p are
down-regulated in hepatocellular carcinoma and exhibit synergistic
effects on cell motility. Front Med. 9:331–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang F, Lee JT, Navolanic PM, Steelman
LS, Shelton JG, Blalock WL, Franklin RA and McCubrey JA:
Involvement of PI3K/Akt pathway in cell cycle progression,
apoptosis, and neoplastic transformation: A target for cancer
chemotherapy. Leukemia. 17:590–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: Its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nicholson KM and Anderson NG: The protein
kinase B/Akt signalling pathway in human malignancy. Cell Signal.
14:381–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bader AG, Kang S, Zhao L and Vogt PK:
Oncogenic PI3K deregulates transcription and translation. Nat Rev
Cancer. 5:921–929. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu QF, Liu P, Li ZY, Zhang CF, Chen SQ, Li
ZH, Zhang GY and Li JC: MiR-103/107 induces tumorigenicity in
bladder cancer cell by suppressing PTEN. Eur Rev Med Pharmacol Sci.
22:8616–8623. 2018.PubMed/NCBI
|
|
38
|
Zheng YB, Xiao K, Xiao GC, Tong SL, Ding
Y, Wang QS, Li SB and Hao ZN: MicroRNA-103 promotes tumor growth
and metastasis in colorectal cancer by directly targeting LATS2.
Oncol Lett. 12:2194–2200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao BS, Liu G, Wang TY, Ji YH, Qi B, Tao
P, Li HC and Wu XN: Screening of microRNA in patients with
esophageal cancer at same tumor node metastasis stage with
different prognoses. Asian Pac J Cancer Prev. 14:139–143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tian Y, Xue Y, Ruan G, Cheng K, Tian J,
Qiu Q, Xiao M, Li H, Yang H and Wang L: Interaction of serum
microRNAs and serum folate with the susceptibility to pancreatic
cancer. Pancreas. 44:23–30. 2015. View Article : Google Scholar
|
|
41
|
Zhuan B, Lu Y, Chen Q, Zhao X, Li P, Yuan
Q and Yang Z: Overexpression of the long noncoding RNA TRHDE-AS1
inhibits the progression of lung cancer via the miRNA-103/KLF4
axis. J Cell Biochem. 120:17616–17624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang D, Wang JJ, Li JS and Xu QY: miR-103
functions as a tumor suppressor by directly targeting programmed
cell death 10 in NSCLC. Oncol Res. 26:519–528. 2018. View Article : Google Scholar
|
|
43
|
Zhang Z, Wu S, Muhammad S, Ren Q and Sun
C: miR-103/107 promote ER stress-mediated apoptosis via targeting
the Wnt3a/ β-catenin/ATF6 pathway in preadipocytes. J Lipid Res.
59:843–853. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang X, Lin Y, Peng L, Sun R, Gong X, Du J
and Zhang X: MicroRNA-103 promotes proliferation and inhibits
apoptosis in spinal osteosarcoma cells by targeting p57. Oncol Res.
26:933–940. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fu X, Zhang W, MSu Y, Lu L, Wang D and
Wang H: MicroRNA-103 suppresses tumor cell proliferation by
targeting PDCD10 in prostate cancer. Prostate. 76:543–551. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Niu R, Tang Y, Xi Y and Jiang D: High
expression of Krüppel-like factor 7 indicates unfavorable clinical
outcomes in patients with lung adenocarcinoma. J Surg Res.
250:216–223. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ma Y, Wu L, Liu X, Xu Y, Shi W, Liang Y,
Yao L, Zheng J and Zhang J: KLF4 inhibits colorectal cancer cell
proliferation dependent on NDRG2 signaling. Oncol Rep. 38:975–984.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhao L, Zhang Y, Liu J, Yin W, Jin D, Wang
D and Zhang W: miR-185 inhibits the proliferation and invasion of
non-small cell lung cancer by targeting KLF7. Oncol Res.
27:1015–1023. 2019. View Article : Google Scholar
|
|
49
|
An YX, Shang YJ, Xu ZW, Zhang QC, Wang Z,
Xuan WX and Zhang XJ: STAT3-induced long noncoding RNA LINC00668
promotes migration and invasion of non-small cell lung cancer via
the miR-193a/KLF7 axis. Biomed Pharmacother. 116:1090232019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Roberts JT and Borchert GM: Computational
prediction of MicroRNA target genes, target prediction databases,
and web resources. Methods Mol Biol. 1617:109–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang X, Li L, Huang Q, Xu W, Cai X, Zhang
J, Yan W, Song D, Liu T, Zhou W, et al: Wnt signaling through
snail1 and zeb1 regulates bone metastasis in lung cancer. Am J
Cancer Res. 5:748–755. 2015.PubMed/NCBI
|
|
52
|
Zhang L, Gallup M, Zlock L, Finkbeiner W
and McNamara NA: P120-catenin modulates airway epithelial cell
migration induced by cigarette smoke. Biochem Biophys Res Commun.
417:49–55. 2012. View Article : Google Scholar
|
|
53
|
Liu S, Ye D, Guo W, Yu W, He Y, Hu J, Wang
Y, Zhang L, Liao Y, Song H, et al: G9a is essential for
EMT-mediated metastasis and maintenance of cancer stem cell-like
characters in head and neck squamous cell carcinoma. Oncotarget.
6:6887–6901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nilsen TW: Mechanisms of microRNA-mediated
gene regulation in animal cells. Trends Genet. 23:243–249. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cullen BR: Transcription and processing of
human microRNA precursors. Mol Cell. 16:861–865. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar :
|
|
57
|
Yousef M, Showe L and Showe M: A study of
microRNAs in silico and in vivo: Bioinformatics approaches to
microRNA discovery and target identification. Febs J.
276:2150–2156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Cui J, Li D, Zhang W, Shen L and Xu X:
Bioinformatics analyses combined microarray identify the
deregulated microRNAs in oral cancer. Oncol Lett. 8:218–222. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Swamynathan SK: Krüppel-like factors:
Three fingers in control. Hum Genomics. 4:263–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Dong JT and Chen C: Essential role of KLF5
transcription factor in cell proliferation and differentiation and
its implications for human diseases. Cell Mol Life Sci.
66:2691–2706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sue N, Jack BH, Eaton SA, Pearson RC,
Funnell AP, Turner J, Czolij R, Denyer G, Bao S, Navajas JC, et al:
Targeted disruption of the basic Krüppel-like factor gene (Klf3)
reveals a role in adipogenesis. Mol Cell Biol. 28:3967–3978. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gray S, Wang B, Orihuela Y, Hong EG, Fisch
S, Haldar S, Cline GW, Kim JK, Peroni OD, Kahn BB and Jain MK:
Regulation of gluconeogenesis by krüppel-like factor 15. Cell
Metab. 5:305–312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Huo X, Li SW, Shi T, Suo A, Ruan Z, Guo H
and Yao Y: Cullin3 promotes breast cancer cells metastasis and
epithelial-mesenchymal transition by targeting BRMS1 for
degradation. Oncotarget. 6:41959–41975. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Dellinger TH, Planutis K, Tewari KS and
Holcombe RF: Role of canonical wnt signaling in endometrial
carcinogenesis. Expert Rev Anticancer Ther. 12:51–62. 2012.
View Article : Google Scholar
|
|
65
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View Article : Google Scholar
|
|
66
|
Choi YS, Shim YM, Kim SH, Son DS, Lee HS,
Kim GY, Han J and Kim J: Prognostic significance of E-cadherin and
beta-catenin in resected stage I non-small cell lung cancer. Eur J
Cardiothorac Surg. 24:441–449. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Leung CO, Mak WN, Kai AK, Chan KS, Lee TK,
Ng IO and Lo RC: Sox9 confers stemness properties in hepatocellular
carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.
Oncotarget. 7:29371–29386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Mao Y, Xu J, Li Z, Zhang N, Yin H and Liu
Z: The role of nuclear β-catenin accumulation in the twist2-induced
ovarian cancer EMT. PLoS One. 8:e782002013. View Article : Google Scholar
|
